Aurora Cannabis (ACB) Net Income Growth (3y) (2020 - 2025)
Aurora Cannabis (ACB) Net Income Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 51.28% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -62.58% |
| 5 | United Therapeutics | 23.01 Bn | 20.85 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.41 Bn | 18.61 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | -17.90% |
| 10 | Aurora Cannabis | 155.11 Mn | 69.87 Mn | 21.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 79.52% |
| Sep 30, 2025 | 26.17% |
| Jun 30, 2025 | 36.69% |
| Mar 31, 2025 | 78.60% |
| Dec 31, 2024 | 26.02% |
| Sep 30, 2024 | -1,050.80% |
| Jun 30, 2024 | 691.36% |
| Mar 31, 2024 | 85.81% |
| Dec 31, 2023 | 84.90% |
| Sep 30, 2023 | -1,030.61% |
| Jun 30, 2023 | -33.69% |
| Dec 31, 2022 | 76.28% |
| Sep 30, 2022 | -36.40% |
| Jun 30, 2022 | 85.55% |
| Mar 31, 2022 | -105.16% |
| Dec 31, 2021 | -30.03% |
| Sep 30, 2021 | -28.37% |
| Jun 30, 2021 | -77.08% |
| Mar 31, 2021 | -75.66% |
| Dec 31, 2020 | -211.23% |